Zimmer Biomet considers divesting dental division: 5 things to know

After declining dental sales, Zimmer Biomet is contemplating divesting its dental products unit, according to The Wall Street Journal.

Here are five things to know:

1. Zimmer Biomet's dental segment offers various products for dental implants and dental restoration. The company sells to dental practices, laboratories and distributors.

2. In 2017, the dental segmented generated $109 million of the company's full-year earnings before interest, tax, depreciation and amortization.

3. Zimmer Biomet reported the segment's 2017 sales topped $418.6 million, a 2.2 percent decline from the prior year. However, these sales are up from 2015 sales of $335.7 million.

4. The company attributed the dental segment sales decline to restructuring in European markets.

5. Zimmer Biomet hired Bank of America Merrill Lynch as an advisor in advance of a potential sale.

More articles on dental:
Drs. Judy Villanyi, Howard Schneider & more: 5 dentists making headlines
Dentsply Sirona preliminary financial report shows $3.99B in 2017 revenue: 5 insights
SC dentist faces 5 months in prison for tax violations: 3 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months